The 340B Rebate Model Is Back with a Start Date

On July 31, 2026, HRSA announced a revised version of the 340B Rebate Model Pilot Program would take effect on January 1, 2027. The new rebate model represents the first time since 340B’s inception that the core payment mechanism itself has shifted, rather than the boundaries around it.

Covered entities have always received their 340B savings at the point of purchase. But now, they must purchase eligible drugs at full price and recover savings through a rebate after claim submission and validation. This shift in payment structure introduces new operational requirements that many organizations have never managed at scale. And as a result, every eligible claim will matter more than ever.

The Discount No Longer Applies Itself 

Historically, the 340B discount used to apply itself at the point of sale. But that will not happen automatically anymore. Covered entities must complete a series of steps, including: accurately identifying, tracking, reporting, and reconciling every eligible transaction. Any error at one of these steps stops an organization from getting its rebate.

Success hinges on whether covered entities can:

• Identify eligible rebate claims automatically.
• Generate manufacturer-ready reporting.
• Reconcile payments received.
• Track outstanding and disputed rebates.
• Maintain complete audit documentation.
• Respond quickly when manufacturers question eligibility.

Without those capabilities, missed claims can become missed revenue.

Operational Complexity Will Increase

Today's 340B workflow largely focuses on determining whether a claim is eligible for 340B pricing. Under the rebate model, that determination becomes just the beginning.

Manufacturers must independently validate eligibility before issuing payment, creating entirely new operational workflows centered around claim-level reporting, payment reconciliation, documentation, and dispute management.

Organizations should begin asking:

• Can our current technology identify rebate-eligible claims automatically?
• How will we reconcile rebate payments?
• What happens when a manufacturer disputes a claim?
• Can we track every claim from submission through payment?
• Do we have complete documentation to support every rebate request?
  
  

This Is a Financial Change

For more than three decades, covered entities realized their 340B savings immediately through discounted purchasing. Under the rebate model, those savings become delayed until manufacturers validate claims and issue payment.

That shift changes more than operations.

Organizations will need to understand:

• How much working capital may be tied up while rebates are pending
• How delayed rebate payments could affect pharmacy purchasing and budgeting
• Whether finance and pharmacy teams are aligned on forecasting rebate receivables
• How disputed or delayed claims could impact cash flow

 340B programs may find themselves managing financial processes they have never needed before.

A New Level of Manufacturer Oversight

The rebate model also introduces a new level of interaction between covered entities and manufacturers. Instead of receiving an automatic upfront discount, organizations should expect ongoing communication related to rebate submissions, payment reconciliation, and claim validation.

As manufacturer participation expands, covered entities may encounter different reporting expectations, payment timelines, reconciliation processes, and dispute resolution requirements.

Organizations relying on manual processes may find it increasingly difficult to manage these additional administrative responsibilities at scale.

Waiting Creates Risk

Organizations cannot afford to wait until every manufacturer announces participation in the rebate model, because it compresses their implementation timeline. They need time to validate processes before the first rebate claims are due. Therefore, covered entities must start evaluating their workflows, reporting processes, internal controls, and technology now.

To prepare, organizations should:

• Evaluate whether current systems support claim-level rebate reporting.
• Understand potential cash flow impacts across participating manufacturers.
• Review reconciliation and denial management workflows.
• Confirm audit documentation and reporting capabilities.
• Identify operational gaps before implementation.

Prepare Now

January 1 is not the finish line. It is the beginning of an entirely new reimbursement process.

The organizations that begin preparing today will have time to validate workflows, strengthen internal controls, and implement the technology needed to support accurate rebate reporting.

Those that wait risk compressing months of operational preparation into just a few short weeks while managing live rebate submissions.

The rebate model rewards preparation, accuracy, and visibility. The window to prepare has officially opened. The question is no longer whether the rebate model is coming, it's whether your organization will be ready when it arrives.